Company / Gross Profit
GeneDx Holdings Corp. Gross Profit History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$298.2M
FY2025
5-year range
-$26.8M / $298.2M
FY2021-FY2025
Trend
+53.4%
vs FY2024
Sector context
#68 of 95
Health Care
What the data says
At $298M, GeneDx Holdings Corp.'s gross profit ranks #68 of 95 in the Health Care sector. Gross Profit has increased for 3 consecutive years, from -$27M in FY2022 to $298M in FY2025.
Based on SEC 10-K filings.
$298M in FY2025 with a 5-year CAGR of +136.5%.
Improved from $90M to $298M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +136.5%
- 10-Year CAGR
- -
Sector benchmark
#68 of 95 in Health CareTop 72% of 95This company $298.2M Sector average $1.9B
▼
-84.1% below sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s gross profit has grown for 3 consecutive years.
- 5-year CAGR of +136.5%, indicating consistent growth.
- In FY2025, gross profit increased 53.4% year-over-year.
- Ranks #68 out of 95 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $298.2M | +53.4% |
| FY2024 | $194.4M | +116.0% |
| FY2023 | $90.0M | +436.5% |
| FY2022 | -$26.8M | -61.1% |
| FY2021 | -$16.6M | -512.4% |
| FY2020 | $4.0M | -95.1% |
| FY2019 | $82.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026